Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

SELL
$6.94 - $14.22 $119,832 - $245,536
-17,267 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$7.99 - $37.6 $38,871 - $182,924
-4,865 Reduced 21.98%
17,267 $139,000
Q3 2019

Nov 13, 2019

SELL
$19.17 - $27.4 $371,322 - $530,738
-19,370 Reduced 46.67%
22,132 $454,000
Q2 2019

Aug 08, 2019

SELL
$22.93 - $42.84 $1.45 Million - $2.71 Million
-63,354 Reduced 60.42%
41,502 $1.08 Million
Q1 2019

May 13, 2019

BUY
$32.69 - $47.91 $69,204 - $101,425
2,117 Added 2.06%
104,856 $4.07 Million
Q4 2018

Feb 14, 2019

SELL
$37.1 - $50.11 $772,088 - $1.04 Million
-20,811 Reduced 16.84%
102,739 $4.33 Million
Q3 2018

Nov 13, 2018

SELL
$36.35 - $55.2 $374,877 - $569,277
-10,313 Reduced 7.7%
123,550 $6.18 Million
Q2 2018

Aug 13, 2018

BUY
$33.85 - $50.65 $4.53 Million - $6.78 Million
133,863 New
133,863 $5.12 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.